About Upstream-binding factor 1-like protein 1
Upstream-binding factor 1-like protein 1 (UBTFL1) is a protein
from Homo sapiens identified by UniProt accession
P0CB47, 393 residues long.
MolForge cross-references it against 0 known binders and
10 disease associations.
Target properties
| Protein name | Upstream-binding factor 1-like protein 1 |
| UniProt accession | P0CB47 |
| Gene | UBTFL1 |
| Organism | Homo sapiens |
| Length | 393 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (10)
Diseases linked to this target (Open Targets).
- urinary metabolite measurement · score 0.17
- lean body mass · score 0.05
- serum metabolite measurement · score 0.04
- hair colour measurement · score 0.03
- self reported educational attainment · score 0.02
- substance abuse · score 0.02
- attention deficit hyperactivity disorder · score 0.02
- antisocial behaviour measurement · score 0.02
- gastric carcinoma · score 0.01
- embryonal carcinoma · score 0.00
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P0CB47-F1 | alphafold | PREDICTED | 70.35 | — |
Amino-acid sequence (393 residues)
MALPRSQGHW SNKDILRLLE CMENNRPSDD NSTFSSTQSH MDWGKVAFKN FSGEMCRLKW LEISCNLRKF GTLKELVLEA KKCVKKMNKS QKYRNGPDFP KRPLTAYNRF FKESWPQYSQ MYPGMRSQEL TKILSKKYRE LPEQMKQKYI QDFRKEKQEF EEKLARFREE HPDLVQKAKK SSVSKRTQNK VQKKFQKNIE EVRSLPKTDR FFKKVKFHGE PQKPPMNGYH KFHQDSWSSK EMQHLSVRER MVEIGRRWQR IPQSQKDHFK SQAEELQKQY KVKLDLWLKT LSPENYAAYK ESTYAKGKNM AMTGGPDPRL KQADPQSSSA KGLQEGFGEG QGLQAAGTDS SQTIWVNCHV SMEPEENRKK DREKEESSNS SDCSSGEEIE VDV
Explore Upstream-binding factor 1-like protein 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets